Joint Nordic Procurement of Pharmaceuticals - 2025 - NF2.1302.a

Offentliggjort

11 juni 2025

Anslået værdi

18.146.993 €

Udførelsessted

DK011

Procedure

Offentligt udbud

Bekendtgørelsesnummer

00373008-2025-01

Reference

96e9d894-f9c6-4087-a328-696fdd71d6eb

Officiel kilde

Officiel kilde

CPV-koder

• 33600000Lægemidler

Beskrivelse

Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. Under this tender group, the pharmaceuticals are tendered under each lot no. for the purpose of supplying the Contracting Authorities as 2 markets (Norway as 1 market and Denmark and Iceland as 1 market) see the tender specification. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.

Delkontrakter (14)

Tildelingskriterier

• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.
• Pris — Price is not the only award criterion and all criteria are stated only in the procurement documents.

Tildelinger

Officielle publikationer

• UDBUD · 00373008-2025-01 · 11 juni 2025
• TED · 00373008-2025 · 11 juni 2025

Andre udbud fra Amgros I/S

• Amgros 2027 1.1174.a · 30 september 2026
• Amgros 2026 1.1581.a · 30 september 2026
• Amgros 2027 1.1171.a · 30 september 2026
• OPLYSNING OM INDGÅELSE AF AMGROS’ IBRUGTAGNINGSAFTALER PÅ UDVALGTE LÆGEMIDLER I 2026 Q4 · 28 september 2026
• Markedsdialog om Amgros' kommende udbud på infusions-/injektionsvæsker med indhold af kulhydrater og elektrolytter. · 28 september 2026
• Amgros 2027 1.1042.b · 24 september 2026
• Amgros 2027 1.1073.a · 24 september 2026
• Amgros 2027 1.1051.b · 23 september 2026
• Amgros 2027 1.1490.a · 23 september 2026
• Amgros 2027 1.1152.a · 23 september 2026

Se alle →

Ofte stillede spørgsmål

Hvad er den anslåede værdi af dette udbud?

Den anslåede værdi offentliggjort af ordregiveren er 18.146.993 €.

Hvem er ordregiver for dette udbud?

Ordregiveren er Amgros I/S (Danmark).

Hvordan kan jeg byde på offentlige udbud i Danmark?

Tilbud afgives via den officielle udbudsportal i Danmark. El Vínculo hjælper dig med at finde udbud og analysere dokumenterne; afgivelsen sker altid hos den officielle kilde.